MMHA 6601 Week 7 Robot Reimbursement Analysis Example

Does the Robot Pay for Itself? Testing Each Link in the Reimbursement Logic for a Surgical Robot at a Community Hospital

Student Name

Walden University

MMHA 6601: Technology and Innovations in Healthcare

Instructor Name

Month Day, Year

Does the Robot Pay for Itself? Testing Each Link in the Reimbursement Logic for a Surgical Robot at a Community Hospital

The Claim

Most surgical referrals from Ridgeway Health Partners, a fictional network of fourteen primary care offices, go to one partner hospital, and that hospital is considering a second surgical robot. The proposal to its board says the robot will pay for itself within five years. Ridgeway's leaders were asked to support the proposal because the network refers most of the hospital's general surgery and gynecology patients, and because the proposal assumes those referrals will grow. This paper tests the claim by breaking it into links, each of which must hold for the conclusion to be true.

The financial case for a robot rests on a chain: payment per case must cover the robot's added cost per case, volume must be high enough to spread fixed costs, and the robot must bring in cases that would otherwise go elsewhere or shorten stays enough to save money. A weakness in any link breaks the chain. Researchers have long noted that robotic surgery can raise total health care costs, mainly because a payer's rate for an operation rarely depends on the tools used to perform it, leaving the hospital to carry the extra expense (Barbash & Glied, 2010).

Link 1: Payment per Case

For most procedures, Medicare and commercial payers do not pay more when a robot is used. A robotic cholecystectomy or hysterectomy generally receives the same payment as the laparoscopic version. The proposal implicitly assumes this, but its summary says robotic cases are "high-margin." That is true only if robotic cases cost less to deliver than the payment, which leads to the next link.

Link 2: Cost per Case

Robotic procedures add costs that laparoscopic procedures do not: the purchase or lease of the robot, an annual service contract and instruments with limited uses. An estimate based on manufacturer financial reports put the added cost of acquisition and operation in the range of several thousand dollars per case, depending on volume (Childers & Maggard-Gibbons, 2018). Operating room time is also often longer, especially early in a surgeon's experience.

Table 1

Illustrative Cost per Case by Annual Volume (Second Robot)

Figures are illustrative, built for this paper. Even at the highest volume, each robotic case costs more than its laparoscopic equivalent.

Link 3: Volume

The proposal assumes the second robot will perform 300 cases a year within two years. The first robot currently performs about 260 cases a year and is not fully booked. A second robot would therefore need mostly new cases, not cases moved from the first robot. National data show robotic surgery spreading rapidly to common general surgery procedures, often replacing laparoscopic surgery rather than open surgery (Sheetz et al., 2020). If the second robot mainly converts laparoscopic cases to robotic ones, it adds cost per case without adding cases.

Ridgeway's referral data matter here. The network's surgical referrals have been stable for three years. The proposal assumes a 20 percent increase, attributed to patients choosing the hospital for robotic surgery. There is no evidence in the proposal for that assumption.

Link 4: Offsetting Savings

The proposal argues that shorter stays will offset added costs. For some procedures, robotic surgery shortens stays compared with open surgery. But for procedures already done laparoscopically, the length-of-stay advantage is small or absent. A national study of kidney surgery found that robotic procedures had similar outcomes and higher costs than laparoscopic ones (Jeong et al., 2017). Shorter stays matter financially only under per-case payment, and only when the comparison is with open surgery.

Link 5: Strategic Value

The strongest argument in the proposal is not financial. Surgeons trained on robots may choose hospitals that have them, and a hospital without enough robot time may lose surgeons and their patients to competitors. That is a recruitment and retention argument, and it may justify the purchase, but it should be stated as such, with its own evidence, rather than hidden inside a payback claim. The evidence would be concrete: how many surgeons the hospital expects to recruit in the next five years, how many of them trained mainly on robots, whether any current surgeons have said they would leave without more robot time and what a departed surgeon's annual case volume is worth to the hospital. With those numbers, the board could compare the robot's cost with the cost of losing surgeons, which is a fair comparison and possibly a winning one.

Residency training reinforces the point. Many general surgery and gynecology residents now perform a large share of their minimally invasive cases robotically, so newly trained surgeons may expect a robot as standard equipment. That trend is a reason for the hospital to plan, but it does not change the per-case arithmetic above.

Summary of the Test

Table 2

Each Link and Whether It Holds

The payback claim fails on its financial links. The strategic case may be valid but needs its own evidence.

Recommendation to Ridgeway

Ridgeway should decline to endorse the proposal's financial claim and should not commit to referral growth it has no basis to promise. It could support a revised proposal that states the strategic case openly, shows the first robot's utilization and lists which procedures will move from open to robotic surgery, where benefits are clearest. The network should also ask the hospital to report patient outcomes and costs for robotic cases by procedure, so referring physicians can advise patients.

Conclusion

The robot does not pay for itself under the proposal's own assumptions, because payment does not rise, costs do and volume is unproven. It may still be worth buying for reasons the proposal does not state clearly. Testing each link separately makes that visible and gives the board a better question to answer.

References

Barbash, G. I., & Glied, S. A. (2010). New technology and health care costs: The case of robot-assisted surgery. New England Journal of Medicine, 363(8), 701-704. https://doi.org/10.1056/NEJMp1006602

Childers, C. P., & Maggard-Gibbons, M. (2018). Estimation of the acquisition and operating costs for robotic surgery. JAMA, 320(8), 835-836. https://doi.org/10.1001/jama.2018.9219

Jeong, I. G., Khandwala, Y. S., Kim, J. H., Han, D. H., Li, S., Wang, Y., Chang, S. L., & Chung, B. I. (2017). Association of robotic-assisted vs laparoscopic radical nephrectomy with perioperative outcomes and health care costs, 2003 to 2015. JAMA, 318(16), 1561-1568. https://doi.org/10.1001/jama.2017.14586

Sheetz, K. H., Claflin, J., & Dimick, J. B. (2020). Trends in the adoption of robotic surgery for common surgical procedures. JAMA Network Open, 3(1), e1918911. https://doi.org/10.1001/jamanetworkopen.2019.18911